A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

Stopped Slow recruitment; Study did not address safety concern raised by European Medicines Agency

Conditions

• Foot Ulcer
• Diabetic Foot
• Skin Ulcer
• Diabetic Neuropathies

Interventions

• DRUG: Becaplermin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.